TL-118 (Teligene)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameTL-118 (Teligene)
Drug Alias Nametropomyosin receptor kinase inhibitor (Teligene)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTropomyosin-related kinase inhibitors
TargetsTropomyosin-related kinase
Therapy Area/IndicationsSolid tumoursCentral Nervous System Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesTeligene Inc
China Registration ClassN/A

Develop Information

Active CompaniesTeligene Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursCentral Nervous System Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A